Zosano closes series B round

Drug delivery company Zosano (Fremont, Calif.) said it closed on $45 million in the second and final tranche of its series B round, bringing the total amount of funds raised to $90 million. Zosano (previously Macroflux), which had previously announced total commitments of $75 million from investors New Enterprise Associates; Nomura Phase4; and HBM Partners, said new investor ProQuest contributed an additional $15 million. Zosano was spun out from Johnson & Johnson (JNJ) subsidiary Alza (Mountain View, Calif.) in October 2006. ...